Babson, bd expand strategic partnership to advance diagnostic blood collection in new care settings

Expanded collaboration agreement to make less invasive blood sample collection more convenient and patient centered austin, texas and franklin lakes, n.j. , may 11, 2022 /prnewswire/ -- babson diagnostics, a science-first, health care technology company, and bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced the expansion of a strategic partnership to move blood sample collection into new care settings, including enabling patients to collect blood samples at home for diagnostic testing.
BDX Ratings Summary
BDX Quant Ranking